Other
Carbon Dioxide
0
Pipeline Programs↗
1
Active Trials↗
2
Companies Involved↗
Carbon Dioxide is an early-stage landscape with 0 programs across 2 companies. The most active players are GSK, Cerevel Therapeutics, LLC.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed7 · 54%
Unknown status4 · 31%
Recruiting1 · 8%
Terminated1 · 8%
Clinical Trials
Trial Activity
13 trials
The Value of Central Venous-arterial Carbon Dioxide Difference
Completed·—·N/A·NCT04761237·118 enrolled
Influence of Caffeine on Psychomotor Vigilance and Carbon Dioxide Tolerance During Graded Hypercapnia
Completed·—·N/A·NCT06636825·29 enrolled
Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease
Unknown status·—·Phase 4·NCT03263624·30 enrolled
Non-invasive Carbon Dioxide Monitoring and Endoscopic Retrograde Cholangiopancreatography Patients
Unknown status·—·N/A·NCT04481308·150 enrolled
The Use of Carbon Dioxide as a Contrast Media for Performing Endovascular Procedures
Unknown status·—·N/A·NCT01861327·120 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)